Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Girish Rajgolikar
Observed name:
G. Rajgolikar
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center,
The Ohio State University
ORCID:
0000-0003-0301-4582
Observed ORCID:
0000-0003-0301-4582
OpenAlex ID:
A5063011616
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance
2020
·
Marco H. Hofmann
, Rajeswaran Mani
, et al.
·
Molecular Cancer Therapeutics
·
84
Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells
1998
·
Girish Rajgolikar
, Kenneth K. Chan
, et al.
·
Breast Cancer Research and Treatment
·
67
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia
2020
·
Rajeswaran Mani
, Girish Rajgolikar
, et al.
·
Cytotherapy
·
19
Recombination activation gene-2-deficient blastocyst complementation analysis reveals an essential role for nuclear factor I-A transcription factor in T-cell activation
2011
·
N. Muthusamy
, H.-C. Chen
, et al.
·
International Immunology
·
3
Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma
2023
·
Chinmayee Goda
, Sofia Kolovich
, et al.
·
Experimental Hematology
·
2
PDF
Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD
2022
·
Pooja Khandelwal
, Vijaya Chaturvedi
, et al.
·
Transplantation Reports
·
1
PDF
Abstract 2496: The landscape of the pre-leukemic bone marrow niche in acute myeloid leukemia
2023
·
Chinmayee Goda
, Rohan Kulkarni
, et al.
·
Cancer Research
Supplementary Data from Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance
2023
·
Marco H. Hofmann
, Rajeswaran Mani
, et al.
Supplementary Data from Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance
2023
·
Marco H. Hofmann
, Rajeswaran Mani
, et al.
Data from Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance
2023
·
Marco H. Hofmann
, Rajeswaran Mani
, et al.
3069 – Expansion of a Novel Leukemia Stem Cell-supporting Cd55+ Fibroblast Population in the Preleukemic Bone Marrow
2023
·
Chinmayee Goda
, Rohan Kulkarni
, et al.
·
Experimental Hematology
Epidermal Growth Factor-like 7 As a Novel Therapeutic Target in Mantle Cell Lymphoma
2021
·
Chinmayee Goda
, Sofia Kolovich
, et al.
·
Blood
Abstract 510: Selective and potent CDK8 inhibitors enhance NK cell activity and promote tumor surveillance
2019
·
Marco H. Hofmann
, Rajeswaran Mani
, et al.
·
Cancer Research
Abstract 510: Selective and potent CDK8 inhibitors enhance NK cell activity and promote tumor surveillance
2019
·
Marco H. Hofmann
, Rajeswaran Mani
, et al.
·
Immunology
Fc engineered anti-CD33mAb potentiates cytotoxicity of mbIL-21 expanded NK-cells against primary AML pre-treated with decitabine
2019
·
R. Mani
, G. Rajgolikar
, et al.
·
Cytotherapy
Show more works
View as search
Works count:
15
Citation count:
176
H-index:
3
I10-index:
3
Year
Topic
Type